0000046619-18-000032.txt : 20180320
0000046619-18-000032.hdr.sgml : 20180320
20180320144930
ACCESSION NUMBER: 0000046619-18-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180316
FILED AS OF DATE: 20180320
DATE AS OF CHANGE: 20180320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MENDELSON VICTOR H
CENTRAL INDEX KEY: 0001031082
STATE OF INCORPORATION: FL
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-04604
FILM NUMBER: 18701625
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEICO CORP
CENTRAL INDEX KEY: 0000046619
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT ENGINES & ENGINE PARTS [3724]
IRS NUMBER: 650341002
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 3000 TAFT ST
CITY: HOLLYWOOD
STATE: FL
ZIP: 33021
BUSINESS PHONE: 954-987-4000
MAIL ADDRESS:
STREET 1: 3000 TAFT STREET
CITY: HOLLYWOOD
STATE: FL
ZIP: 33021
FORMER COMPANY:
FORMER CONFORMED NAME: HEINICKE INSTRUMENTS CO
DATE OF NAME CHANGE: 19860417
4
1
wf-form4_152157175691276.xml
FORM 4
X0306
4
2018-03-16
0
0000046619
HEICO CORP
HEI, HEI.A
0001031082
MENDELSON VICTOR H
825 BRICKELL BAY DRIVE, SUITE 1644
MIAMI
FL
33131
1
1
0
0
Co-President
Option (Right to purchase Common Stock)
13.7233
2020-09-13
Common Stock
305176.0
305176
D
Option (Right to purchase Common Stock)
19.9189
2021-09-12
Common Stock
244141.0
244141
D
Option (Right to purchase Common Stock)
26.7622
2023-06-10
Common Stock
97656.0
97656
D
Option (Right to purchase Common Stock)
37.088
2025-06-08
Common Stock
78125.0
78125
D
Option (Right to purchase Common Stock)
31.1872
2025-12-14
Common Stock
78125.0
78125
D
Option (Right to purchase Common Stock)
56.2048
2027-03-17
Common Stock
156250.0
156250
D
Option (Right to purchase Class A Common Stock)
19.3126
2023-06-10
Class A Common Stock
97656.0
97656
D
Option (Right to purchase Common Stock)
88.32
2018-03-16
4
A
0
100000
0
A
2028-03-16
Common Stock
100000.0
100000
D
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 305,176 shares of Common Stock at an exercise price of $13.7233 per share, as adjusted for stock splits and stock dividends. These Options became exercisable on various dates and expire on September 13, 2020.
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 244,141 shares of Common Stock at an exercise price of $19.9189 per share, as adjusted for stock splits and stock dividends. These Options became exercisable on various dates and expire on September 12, 2021
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 97,656 shares of Common Stock at an exercise price of $26.7622 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June 10, 2023.
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 78,125 shares of Common Stock at an exercise price of $37.088 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June 8, 2025.
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 78,125 shares of Common Stock at an exercise price of $31.1872 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on December, 14 2025.
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 156,250 shares of Common Stock at an exercise price of $56.2048 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on March, 17 2027.
The Reporting Person owns directly Options entitling the Reporting Person to purchase an aggregate of 97,656 shares of Class A Common Stock at an exercise price of $19.3126 per share, as adjusted for stock splits and stock dividends. These Options become exercisable on various dates and expire on June, 10 2023.
These options become exercisable 20% per year over five years from the date of Grant.
/s/ Victor H. Mendelson
2018-03-20